other : joint canada-israel health research program phase ii (2021 funding opportunity)
for an application to be eligible:
- for administrative purposes only, the nominated principal applicant must be the canadian investigator co-leading the team.
- nominated principal applicant (npa) must be an independent researcher appointed at an eligible institution (see the cihr application administration guide – part 4).
- a maximum of one principal applicant must be the israeli investigator co-leading the team.
- a maximum of one principal applicant must be the lmic investigator co-leading the team.
- for the canadian arm of the team, applications involving first nations, inuit, métis and/or urban indigenous populations must include at least one participant who self-identifies as first nations, inuit, or métis and/or who can demonstrate their experience of meaningful and culturally safe involvement with indigenous peoples in an indigenous health research environment on the research team. at least one participant meeting this criteria must submit an "other" attachment describing their experience working in an indigenous health research environment.
- if relevant, the lmic investigator co-leading the team is invited to reflect on how their research application could involve indigenous populations related to their specific context.
- in your knowledge mobilization plan, as a minimum eligibility requirement, all proposals must support at least one of the following activities aimed at supporting capacity and scientific relationships:
- significant training opportunities such as scientific workshops, graduate training in low- and middle-income countries, canada and israel or summer schools benefiting researchers/trainees in eligible low and middle income countries; and/or
- inclusion of trainees from low and middle income countries, canada and israel in carrying out the research.
notes:
- each canadian, israeli, and lmic investigator co-leading a team can only submit and/or participate in one application in the competition.
- canadian, israeli, and lmic investigators co-leading a team are not eligible to hold a grant under this competition if they hold an active grant from phase i of the jcihrp at the funding start date for this funding opportunity.
- the canadian, israeli, and lmic investigators co-leading a team are strongly encouraged to complete one of the sex- and gender-based analysis training modules available online through the cihr institute of gender and health and submit a certificate of completion. applicants should select and complete the training module most applicable to their research project. applicants are encouraged to review the “how to integrate sex and gender in research” section of the cihr website.
applications that do not meet the eligibility criteria outlined above will be withdrawn from the competition.
for more information, please contact jill sherman, intl.research@lakeheadu.ca.
phase ii of the joint canada-israel health research program is expected to:
- advance research and discovery in global health and biomedical sciences;
- encourage scientific collaboration and knowledge mobilization between canadian, israeli and lmic researchers and trainees; and
- reinforce capacity in global health and biomedical science with researchers and trainees.
msca staff exchanges - call for applications
the msca staff exchanges program supports mobility of researchers through secondments to academic and industry partners in europe and internationally. the aim of the program is to promote knowledge exchange and skills development, leading to sustainable collaborative projects between organisations from the academic and non-academic sectors (including smes) in europe and beyond. staff exchanges are open to international consortia of universities, research institutions, businesses, smes and other non-academic organizations. currently, canadian research teams can participate under the rules for third party countries - msca funds could be used to support visiting researchers to lakehead (faculty and research staff, including phd 世界杯2022赛程表淘汰赛 ). "staff" can include phd 世界杯2022赛程表淘汰赛 and post-doctoral researchers, as well as administrative, technical or managerial staff. secondments can last from one month to one year. graduate 世界杯2022赛程表淘汰赛 of canadian participants in an msca project can participate in outbound mobility through a tier 1 mitacs gra award (no co-pay requirement). projects can last up to four years, and require partners in at least three countries, two of which must be in an eu member state or associated country. for more information, please contact jill sherman, intl.research@lakeheadu.ca.
horizon europe
ontario vehicle innovation network (ovin): r&d partnership fund - electric vehicle (ev)
eligible projects
- minimum one applicant and a partner (an applicant is an sme defined as having fewer than 500 full-time employees) with a minimum 2:1 contribution match by applicants and/or private sector partners
- applicants and partners are required to have operations in ontario and carry out their projects in the province
- projects last up to 24 months in duration
- funded projects will focus on technologies in vehicles or those in transportation systems and infrastructure related r&d outside vehicles.
- this program is not intended to prove feasibility or for basic technology research. projects should be at technology readiness level 3-9.
- typical project activities include technology development, demonstration, product/service validation, testing and proof of concept
eligible partners
- small and medium-sized enterprises (smes)
- national and multinational enterprises (nes and mnes)
- publicly funded post-secondary academic institutions
- municipalities
- indigenous communities
- not-for-profit organizations
projects must be carried out between one sme, the applicant and one partner from the participants list. additional partners can also join the project. publicly funded post-secondary institutions cannot act as applicants. there is no limit on the number of partners. partnerships should represent significant potential commercial opportunities for all industry applicants and partners.
this program is ideal for small- and medium-sized companies that require co-investment and the support of strategic partners to develop, test, validate and commercialize electric vehicle (ev) and battery-focused technologies, including ev related technologies.
ontario centre of innovation
2022 woo network - call for concepts
the oicr window-of-opportunity network is pleased to release its 2022 call for concepts. details, concept application form, and important deadlines can be found at oicr.on.ca/woo-trial-call-for-concepts.
background:
the woo network was formed in 2020 and is co-led by drs. angel arnaout (the ottawa hospital) and melanie spears (oicr) to propel a clinical-translational research program where novel therapies are quickly tested in cancer patients prior to surgery. the network provides prioritized woo studies with trial development support, funding, translational analysis, and knowledge dissemination. the woo network also builds study capacity through mentoring of new investigators, industry partnerships, patient engagement, data analysis and sharing network expertise.
concept focus:
the initial scientific focus of the network is immunomodulation, to understand the biology of how therapeutics can elicit an immune response and alter the immune environment in tumours. this is critical to make immunotherapy more effective, less toxic, and more durable. please refer to the portfolio concept call [pdf] for more detail.
evaluation criteria:
applications will be accepted from oncology researchers affiliated with not-for-profit research organizations in ontario. concepts will be evaluated based on the following key criteria of woo network trials:
- pre-surgical design
- small, multi-centre, with less than 100 patients
- focus on immunomodulation with identification of novel biomarkers of immune response
- demonstrated drug safety profile
- highly engaged principal investigators and co-investigators, including surgeons and oncologists
- embedded patient partnership
- feasibility for patient accrual completed within two years, with ethics approval, study start-up and first patient accrued within the first two quarters after funding approval
funding available:
up to $450,000 total per trial, over two years.
key dates:
- concept deadline: february 7, 2022, 12 p.m. est
- concept presentation: march 29, 2022, during network meeting (10 a.m. – 12 p.m. est)
- full application deadline: may 16, 2022, 12 p.m. est
partnership engage grants
partnership engage grants are expected to respond to the objectives of the insight program and the connection program. however, partnership engage grants cannot respond exclusively to the objectives of the connection program.
these grants provide short-term and timely support for partnered research activities that will inform decision-making at a single partner organization from the public, private or not-for-profit sector. the small-scale, stakeholder-driven partnerships supported through partnership engage grants are meant to respond to immediate needs and time constraints facing organizations in non-academic sectors. in addressing an organization-specific need, challenge and/or opportunity, these partnerships let non-academic organizations and postsecondary researchers access each other’s unique knowledge, expertise and capabilities on topics of mutual interest.
call for proposals
clinical partnerships
these grants offer funding opportunities for clinicians to validate glycomics data from clinical studies. maximum request: $50,000 for one year. download pdf request for proposals >>
translational grants
these grants further advance/translate projects with proof of concept and protected ip. maximum request: $150,000 for one year, 1:1 matching required. download pdf request for proposals >>
strategic initiatives
these grants fund partner-led initiatives to advance a partner challenge. maximum request: $150,000 for one year, with possibility of one year renewal, 1:1 matching required. download pdf request for proposals >>
international partnerships
glyconet has formalized a partnership with academia sinica to co-fund collaborative research between two entities. these grants fund projects that involve at least two groups, one in canada and one in taiwan. glyconet will fund research conducted in canada, while academia sinica will fund research conducted in taiwan. projects require at least a 1:1 matching and must be completed within 12 months. download pdf request for proposals >>
idea to innovation grants
the objective of the idea to innovation (i2i) grants is to accelerate the pre-competitive development of promising technology originating from the university and college sector and promote its transfer to a new or established canadian company. the i2i grants provide funding to college and university faculty members to support research and development projects with recognized technology transfer potential. this is achieved through defined phases by providing crucial assistance in the early stages of technology validation and market connection.